Rezolute, Inc. (RZLT)
4.575
+0.04
(+0.77%)
USD |
NASDAQ |
Sep 04, 16:00
4.575
0.00 (0.00%)
After-Hours: 18:03
Rezolute Cash and Short Term Investments (Annual) : 167.86M for June 30, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | 167.86M |
| June 30, 2024 | 126.87M |
| June 30, 2023 | 101.90M |
| June 30, 2022 | 150.41M |
| June 30, 2021 | 41.05M |
| June 30, 2020 | 9.955M |
| June 30, 2019 | 11.57M |
| June 30, 2018 | 1.646M |
| Date | Value |
|---|---|
| June 30, 2017 | 4.486M |
| June 30, 2016 | 4.062M |
| June 30, 2015 | 5.729M |
| June 30, 2014 | 5.934M |
| June 30, 2013 | 0.0005M |
| June 30, 2012 | 0.0051M |
| June 30, 2011 | 0.037M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | 71.89M |
| AbbVie, Inc. | 5.257B |
| Marker Therapeutics, Inc. | 17.04M |
| Avalo Therapeutics, Inc. | 98.37M |
| Krystal Biotech, Inc. | 827.79M |